SESSION 6: Workshops
Tuesday • May 7, 2024 • 2:00–5:00 PM • Arizona Ballroom Salons 1-5, 8-12, San Luis and San Pedro
The following companies will host 45-minute interactive presentations on new technologies related to aerosol drug delivery.
Meeting participants can attend up to THREE of these sessions.
Empowering the Path to Clinical: Innovative Strategies for De-Risking Product Development
Will Ganley, Jonathan Mulpas and Sara Pinto
Manufacturing pMDIs using Ultra-low Global Warming Potential Propellant HFO-1234ze(E)
Nick Atkinson and Gregory Smith
Build Your Own Soft Mist Inhaler
Herbert Wachtel, Kai Berkenfeld, David Stadermann and Sitaram Velaga
Practical Considerations for Development and Scale-up of Spray Dried Inhalation Powders
Alan Watts and Thomas Lund
Automating Inhaled and Nasal Product Testing: Lower Variability, Higher Productivity
Clair Brooks and Matthew Fenn
A Modular Approach to Understand the Design Space of a Capsule-Based High-performance DPI
Anselm Ebert and Mirjam Kobler
Nasal Powders: Formulation and Device Integration
Dina Morais and Claudia Costa
Exploring In Vitro Only Bioequivalence Pathways for Generic Nasal Suspensions
Ben Stafford and Chris Vernall
Considering a Green pMDI?: Q&A to Navigate an Evolving Regulatory Landscape
Andy Burns, Ann Purrington, Nick Smalley and Jon Walder
Integrated Carrier-Based Formulation Development: Process and Performance Considerations
Beatriz Noriega Fernandes
Blending Optimization in Multi-Component DPI Formulations
Rebekka Spellerberg and Stefano Biserni
A New Approach to Optimize Delivery Performance and Treatment Time in Breath-Triggered Nebulizers
Michael Hahn and Rupa Ram
